105 related articles for article (PubMed ID: 7766682)
21. Study of the peptidasic site of cholinesterase: preliminary results.
Chatonnet A; Masson P
FEBS Lett; 1985 Mar; 182(2):493-8. PubMed ID: 2579854
[TBL] [Abstract][Full Text] [Related]
22. Microcalorimetric study of the inhibition of butyrylcholinesterase by paraoxon.
Debord J; Harel M; Verneuil B; Bollinger JC; Dantoine T
Anal Biochem; 2009 Jun; 389(2):97-101. PubMed ID: 19341699
[TBL] [Abstract][Full Text] [Related]
23. Crystallographic snapshots of nonaged and aged conjugates of soman with acetylcholinesterase, and of a ternary complex of the aged conjugate with pralidoxime.
Sanson B; Nachon F; Colletier JP; Froment MT; Toker L; Greenblatt HM; Sussman JL; Ashani Y; Masson P; Silman I; Weik M
J Med Chem; 2009 Dec; 52(23):7593-603. PubMed ID: 19642642
[TBL] [Abstract][Full Text] [Related]
24. Retrospective detection of exposure to nerve agents: analysis of phosphofluoridates originating from fluoride-induced reactivation of phosphylated BuChE.
van der Schans MJ; Polhuijs M; van Dijk C; Degenhardt CE; Pleijsier K; Langenberg JP; Benschop HP
Arch Toxicol; 2004 Sep; 78(9):508-24. PubMed ID: 15170525
[TBL] [Abstract][Full Text] [Related]
25. Phosphobutyrylcholinesterase: phosphorylation of the esteratic site of butyrylcholinesterase by ethephon [(2-chloroethyl)phosphonic acid] dianion.
Haux JE; Quistad GB; Casida JE
Chem Res Toxicol; 2000 Jul; 13(7):646-51. PubMed ID: 10898597
[TBL] [Abstract][Full Text] [Related]
26. Inhibition of human plasma and serum butyrylcholinesterase (EC 3.1.1.8) by alpha-chaconine and alpha-solanine.
Nigg HN; Ramos LE; Graham EM; Sterling J; Brown S; Cornell JA
Fundam Appl Toxicol; 1996 Oct; 33(2):272-81. PubMed ID: 8921346
[TBL] [Abstract][Full Text] [Related]
27. Structure, activities and biomedical applications of human butyrylcholinesterase.
Masson P; Carletti E; Nachon F
Protein Pept Lett; 2009; 16(10):1215-24. PubMed ID: 19508180
[TBL] [Abstract][Full Text] [Related]
28. Resolving pathways of interaction of mipafox and a sarin analog with human acetylcholinesterase by kinetics, mass spectrometry and molecular modeling approaches.
Mangas I; Taylor P; Vilanova E; Estévez J; França TC; Komives E; Radić Z
Arch Toxicol; 2016 Mar; 90(3):603-16. PubMed ID: 25743373
[TBL] [Abstract][Full Text] [Related]
29. Protection by butyrylcholinesterase against organophosphorus poisoning in nonhuman primates.
Broomfield CA; Maxwell DM; Solana RP; Castro CA; Finger AV; Lenz DE
J Pharmacol Exp Ther; 1991 Nov; 259(2):633-8. PubMed ID: 1941611
[TBL] [Abstract][Full Text] [Related]
30. Revisiting the reactivity of oximate alpha-nucleophiles with electrophilic phosphorus centers. Relevance to detoxification of sarin, soman and DFP under mild conditions.
Terrier F; Rodriguez-Dafonte P; Le Guével E; Moutiers G
Org Biomol Chem; 2006 Dec; 4(23):4352-63. PubMed ID: 17102881
[TBL] [Abstract][Full Text] [Related]
31. Engineering Dynamic Surface Peptide Networks on Butyrylcholinesterase
Hester KP; Bhattarai K; Jiang H; Agarwal PK; Pope C
Chem Res Toxicol; 2019 Sep; 32(9):1801-1810. PubMed ID: 31411024
[TBL] [Abstract][Full Text] [Related]
32. Asymmetric fluorogenic organophosphates for the development of active organophosphate hydrolases with reversed stereoselectivity.
Amitai G; Adani R; Yacov G; Yishay S; Teitlboim S; Tveria L; Limanovich O; Kushnir M; Meshulam H
Toxicology; 2007 Apr; 233(1-3):187-98. PubMed ID: 17129656
[TBL] [Abstract][Full Text] [Related]
33. Nanocrystalline metal oxides as destructive adsorbents for organophosphorus compounds at ambient temperatures.
Rajagopalan S; Koper O; Decker S; Klabunde KJ
Chemistry; 2002 Jun; 8(11):2602-7. PubMed ID: 12180340
[TBL] [Abstract][Full Text] [Related]
34. Biomarkers of organophosphorus nerve agent exposure: comparison of phosphylated butyrylcholinesterase and phosphylated albumin after oxime therapy.
Read RW; Riches JR; Stevens JA; Stubbs SJ; Black RM
Arch Toxicol; 2010 Jan; 84(1):25-36. PubMed ID: 19862504
[TBL] [Abstract][Full Text] [Related]
35. Crystal structures of aged phosphonylated acetylcholinesterase: nerve agent reaction products at the atomic level.
Millard CB; Kryger G; Ordentlich A; Greenblatt HM; Harel M; Raves ML; Segall Y; Barak D; Shafferman A; Silman I; Sussman JL
Biochemistry; 1999 Jun; 38(22):7032-9. PubMed ID: 10353814
[TBL] [Abstract][Full Text] [Related]
36. Crystal structures of acetylcholinesterase in complex with organophosphorus compounds suggest that the acyl pocket modulates the aging reaction by precluding the formation of the trigonal bipyramidal transition state.
Hörnberg A; Tunemalm AK; Ekström F
Biochemistry; 2007 Apr; 46(16):4815-25. PubMed ID: 17402711
[TBL] [Abstract][Full Text] [Related]
37. The rs662 polymorphism of paraoxonase 1 affects the difference in the inhibition of butyrylcholinesterase activity by organophosphorus pesticides in human blood.
Nam DC; Ha YM; Park MK; Cho SK
Int J Clin Pharmacol Ther; 2016 Aug; 54(8):622-7. PubMed ID: 27087156
[TBL] [Abstract][Full Text] [Related]
38. Development of molecular probes for the identification of extra interaction sites in the mid-gorge and peripheral sites of butyrylcholinesterase (BuChE). Rational design of novel, selective, and highly potent BuChE inhibitors.
Campiani G; Fattorusso C; Butini S; Gaeta A; Agnusdei M; Gemma S; Persico M; Catalanotti B; Savini L; Nacci V; Novellino E; Holloway HW; Greig NH; Belinskaya T; Fedorko JM; Saxena A
J Med Chem; 2005 Mar; 48(6):1919-29. PubMed ID: 15771436
[TBL] [Abstract][Full Text] [Related]
39. Soman inhibition of butyrylcholinesterase in the presence of substrate: pressure and temperature perturbations.
Cléry C; Masson P; Heiber-Langer I; Balny C
Biochim Biophys Acta; 1992 Oct; 1159(3):295-302. PubMed ID: 1390935
[TBL] [Abstract][Full Text] [Related]
40. Refined crystal structures of "aged" and "non-aged" organophosphoryl conjugates of gamma-chymotrypsin.
Harel M; Su CT; Frolow F; Ashani Y; Silman I; Sussman JL
J Mol Biol; 1991 Oct; 221(3):909-18. PubMed ID: 1942036
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
